DOI QR코드

DOI QR Code

High-grade mucoepidermoid carcinoma in the thyroid gland with poor prognosis

  • Received : 2021.01.25
  • Accepted : 2021.02.08
  • Published : 2021.04.30

Abstract

Mucoepidermoid carcinoma (MEC) is the most common malignant neoplasm of the salivary gland, but primary thyroid MEC has rarely been reported and usually has a good prognosis. Herein, I report a case of thyroidal MEC with a poor prognosis in an 82-year-old woman with an anterior neck mass. Ultrasonography and computed tomography revealed a thyroid mass. The patient initially underwent fine-needle aspiration, was diagnosed with malignancy, and underwent a right lobectomy. On gross examination, a 4.0×3.6×2.6 cm-sized ill-defined, unencapsulated, and infiltrative tan to whitish mass with necrosis was identified. Microscopically, epidermoid tumor cell nests or solid sheets were identified. Mucous cells that were positive for periodic acid-Schiff and mucicarmine stains were also identified within epidermoid cell nests. Frequent mitosis and necrosis were observed. Immunohistochemical staining for p40 and p63 was positive, and that for thyroid transcription factor-1 and paired box gene 8 was focally positive. According to the Armed Forces Institute of Pathology grading system for salivary gland MEC, the current case was classified as high-grade MEC. After surgery, the patient suffered from dyspnea due to a remnant neck mass that compressed and obstructed the trachea; therefore, the patient refused further treatment. Thyroidal MECs are considered low-grade with a favorable prognosis, but there are several reported cases of thyroidal MEC with poor prognosis. The current case is a rare presentation of high-grade thyroidal MEC with a poor prognosis.

Keywords

References

  1. Le QV, Ngo DQ, Ngo QX. Primary mucoepidermoid carcinoma of the thyroid: a report of a rare case with bone metastasis and review of the literature. Case Rep Oncol 2019;12:248-59. https://doi.org/10.1159/000498917
  2. Bhandarkar ND, Chan J, Strome M. A rare case of mucoepidermoid carcinoma of the thyroid. Am J Otolaryngol 2005;26:138-41. https://doi.org/10.1016/j.amjoto.2004.08.014
  3. Goode RK, Auclair PL, Ellis GL. Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria. Cancer 1998;82:1217-24. https://doi.org/10.1002/(SICI)1097-0142(19980401)82:7<1217::AID-CNCR2>3.0.CO;2-C
  4. Lee K, Mirza O, Dobbs S, Jayaram S. Poorly differentiated mucoepidermoid carcinoma of the thyroid. BMJ Case Rep 2020;13:e236539. https://doi.org/10.1136/bcr-2020-236539
  5. Luna MA. Salivary mucoepidermoid carcinoma: revisited. Adv Anat Pathol 2006;13:293-307. https://doi.org/10.1097/01.pap.0000213058.74509.d3
  6. Brandwein MS, Ivanov K, Wallace DI, Hille JJ, Wang B, Fahmy A, et al. Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading. Am J Surg Pathol 2001;25:835-45. https://doi.org/10.1097/00000478-200107000-00001
  7. Prichard RS, Lee JC, Gill AJ, Sywak MS, Fingleton L, Robinson BG, et al. Mucoepidermoid carcinoma of the thyroid: a report of three cases and postulated histogenesis. Thyroid 2012;22:205-9. https://doi.org/10.1089/thy.2011.0276
  8. Butler RT, Spector ME, Thomas D, McDaniel AS, McHugh JB. An immunohistochemical panel for reliable differentiation of salivary duct carcinoma and mucoepidermoid carcinoma. Head Neck Pathol 2014;8:133-40. https://doi.org/10.1007/s12105-013-0493-5
  9. McHugh CH, Roberts DB, El-Naggar AK, Hanna EY, Garden AS, Kies MS, et al. Prognostic factors in mucoepidermoid carcinoma of the salivary glands. Cancer 2012;118:3928-36. https://doi.org/10.1002/cncr.26697
  10. Minagawa A, Iitaka M, Suzuki M, Yasuda S, Kameyama K, Shimada S, et al. A case of primary mucoepidermoid carcinoma of the thyroid: molecular evidence of its origin. Clin Endocrinol (Oxf) 2002;57:551-6. https://doi.org/10.1046/j.1365-2265.2002.01599.x
  11. Ando M, Nakanishi Y, Asai M, Maeshima A, Matsuno Y. Mucoepidermoid carcinoma of the thyroid gland showing marked ciliation suggestive of its pathogenesis. Pathol Int 2008;58:741-4. https://doi.org/10.1111/j.1440-1827.2008.02303.x
  12. Vazquez Ramirez F, Otal Salaverri C, Argueta Manzano O, Galera Ruiz H, Gonzalez-Campora R. Fine needle aspiration cytology of high grade mucoepidermoid carcinoma of the thyroid: a case report. Acta Cytol 2000;44:259-64. https://doi.org/10.1159/000326372
  13. Setia N, Barletta JA. Poorly differentiated thyroid carcinoma. Surg Pathol Clin 2014;7:475-89. https://doi.org/10.1016/j.path.2014.08.001
  14. Ragazzi M, Ciarrocchi A, Sancisi V, Gandolfi G, Bisagni A, Piana S. Update on anaplastic thyroid carcinoma: morphological, molecular, and genetic features of the most aggressive thyroid cancer. Int J Endocrinol 2014;2014:790834.
  15. Shah AA, La Fortune K, Miller C, Mills SE, Baloch Z, LiVolsi V, et al. Thyroid sclerosing mucoepidermoid carcinoma with eosinophilia: a clinicopathologic and molecular analysis of a distinct entity. Mod Pathol 2017;30:329-39. https://doi.org/10.1038/modpathol.2016.180
  16. Suzuki A, Hirokawa M, Takada N, Higuchi M, Yamao N, Kuma S, et al. Diagnostic significance of PAX8 in thyroid squamous cell carcinoma. Endocr J 2015;62:991-5. https://doi.org/10.1507/endocrj.EJ15-0226
  17. Rossi ED, Faquin WC, Pantanowitz L. Cytologic features of aggressive variants of follicular-derived thyroid carcinoma. Cancer Cytopathol 2019;127:432-46. https://doi.org/10.1002/cncy.22136
  18. Collins JA, Ping B, Bishop JA, Ali SZ. Carcinoma showing thymus-like differentiation (CASTLE): cytopathological features and differential diagnosis. Acta Cytol 2016;60:421-8. https://doi.org/10.1159/000448836